Pyoderma Gangrenosum: A Patient Guide
At a Glance
Pyoderma gangrenosum is a noncontagious immune-driven skin disease that causes painful, rapidly enlarging ulcers. It requires medical evaluation to distinguish it from dangerous infection, with treatment usually combining immune-calming medicine and gentle wound care.
Important: Do not self-diagnose or delay emergency care. This guide cannot determine whether an ulcer is PG or a dangerous infection. Seek immediate emergency care if your ulcer is rapidly worsening, if the skin turns gray or black quickly, or if you develop a fever, chills, confusion, or feel systemically unwell.
Pyoderma gangrenosum (PG) is a rare and often painful skin condition that belongs to a group of disorders known as neutrophilic dermatoses. Although the word “pyoderma” suggests a bacterial infection and “gangrenosum” implies gangrene, PG is neither infectious nor contagious [1]. Instead, it is an autoinflammatory disease, meaning the body’s own immune system—specifically white blood cells called neutrophils—mistakenly attacks healthy skin, leading to the rapid development of deep, painful ulcers [2]. Because the underlying inflammation is “sterile,” antibiotics alone do not treat the underlying PG; however, ulcers can develop secondary infections, and immunosuppression can worsen an unrecognized infection. The focus of care is on calming the overactive immune response while closely monitoring for any true infection.
One of the most defining characteristics of PG is a phenomenon called pathergy, where minor trauma to the skin can trigger new or worsening ulcers [3]. This sensitivity makes the diagnosis particularly high-stakes. In many other types of non-healing wounds, doctors perform “debridement”—the surgical cutting away of tissue—to stimulate healing. However, in a patient with PG, aggressive surgical debridement of viable active PG is generally avoided, as the trauma of the procedure often causes the ulcer to expand rapidly [4]. Distinguishing PG from a true bacterial infection like necrotizing fasciitis is critical to ensure that patients receive appropriate treatments; but suspected serious infection requires urgent treatment, and life-saving source control or debridement must never be withheld when a dangerous infection is suspected [5].
The appearance of PG on the skin is frequently a signal of what is happening inside the rest of the body. More than half of all people diagnosed with the condition have an associated systemic disease, most commonly inflammatory bowel disease (such as Crohn’s or ulcerative colitis), inflammatory arthritis, or certain blood disorders [6]. Because of these strong links, a diagnosis of PG often marks the beginning of a broader health evaluation to identify and treat any underlying “engine” that might be driving the inflammation in the skin.
Managing this condition requires a coordinated, gentle approach. Treatment typically involves a combination of systemic immunosuppression to turn off the body’s internal “alarm” and careful, atraumatic wound care to protect the skin while it repairs itself [7]. While the road to healing can be long and the pain can be significant, understanding the unique biology of the condition helps your care team move away from ineffective treatments and toward a strategy that targets the root cause of the inflammation. Knowing that this is an immune misfire, rather than a failure of hygiene or a simple infection, is the first step toward reclaiming your health and finding a path to remission.
In this guide
6 chapters
Understanding Pyoderma Gangrenosum
Learn what causes pyoderma gangrenosum, why painful ulcers spread quickly, how immune cells drive inflammation, and how pathergy after trauma can worsen wounds.
Clinical Patterns and Associated Conditions
Learn how pyoderma gangrenosum patterns relate to inflammatory bowel disease, arthritis, and blood disorders, and when doctors may recommend blood tests.
Diagnostic Criteria, Biopsy, and Pitfalls
Learn how pyoderma gangrenosum is diagnosed, including biopsy, PARACELSUS and Delphi criteria, necrotizing fasciitis warning signs, and pathergy risks.
Systemic Treatments and Monitoring
Learn about systemic treatments for pyoderma gangrenosum, including steroids, cyclosporine, biologics, infection risks, safety tests, and vaccination guidance.
Wound Care and Pain Management Strategy
Learn how to care for a pyoderma gangrenosum ulcer with gentle dressings, safe debridement, ostomy leak control, and individualized pain relief options.
Long-Term Recovery and Life After Healing
Learn what to expect after pyoderma gangrenosum heals, including cribriform scars, recurrence warning signs, surgery precautions, monitoring and support.
Common questions in this guide
What is pyoderma gangrenosum, and is it an infection?
Can a small injury or procedure make pyoderma gangrenosum worse?
What other health conditions are associated with pyoderma gangrenosum?
How is pyoderma gangrenosum treated?
When should I seek emergency care for a skin ulcer?
Can a biopsy be done if pyoderma gangrenosum is suspected?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my wound being treated as an inflammatory condition or as a potential infection?
- 2.Have we already screened for the systemic conditions—like bowel or joint issues—that often accompany this skin condition?
- 3.What steps are we taking to ensure my wound is protected from further trauma or aggressive cleaning?
- 4.If we decide on a biopsy, what precautions will you take to minimize the risk of the wound growing larger?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (7)
- 1
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
Maronese CA, Pimentel MA, Li MM, et al.
American journal of clinical dermatology 2022; (23(5)):615-634 doi:10.1007/s40257-022-00699-8.
PMID: 35606650 - 2
Pyoderma gangrenosum: a review of pathogenesis and treatment.
Ahn C, Negus D, Huang W
Expert review of clinical immunology 2018; (14(3)):225-233 doi:10.1080/1744666X.2018.1438269.
PMID: 29406827 - 3
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.
Maverakis E, Ma C, Shinkai K, et al.
JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.
PMID: 29450466 - 4
Assessing the role of wound debridement in pyoderma gangrenosum-A retrospective cohort study.
Bar D, Beberashvili I
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2024; (32(6)):941-948 doi:10.1111/wrr.13219.
PMID: 39262283 - 5
Postoperative Pyoderma Gangrenosum Following Varicose Vein Surgery: Recognizing a Rare Surgical Mimic Before Extensive Tissue Loss.
El Salawi O, Dubois M, De Smet A
Cureus 2026; (18(7)):e113733 doi:10.7759/cureus.113733.
PMID: 42544110 - 6
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.
Kridin K, Cohen AD, Amber KT
American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.
PMID: 29721816 - 7
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F, Polymeros D, Panagiotou M, et al.
Acta dermatovenerologica Croatica : ADC 2016; (24(1)):83-5.
PMID: 27149138
This guide is for informational purposes only and does not constitute medical advice. A rapidly worsening ulcer or signs of infection require urgent evaluation, and your clinician should guide diagnosis and treatment.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.